The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...

A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that ...

Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...

New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.

The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...

Recent research has revealed compelling evidence supporting tenecteplase as a more effective treatment for ischemic strokes compared to traditional alteplase therapy. This discovery could mark a major ...

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.

A new University of Manchester and Edinburgh study published in the journal Brain, Behavior and Immunity has found that ...

Triage from the emergency department to an angiographic operating room requires activation of specially trained personnel and patient transport to remote locations in the hospital facility. To ...